|
HS Code |
519851 |
As an accredited 5-Bromo-3-Fluoropyridine-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-3-Fluoropyridine-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In today’s world of chemical synthesis, 5-Bromo-3-Fluoropyridine-2-Carboxylic Acid stands out for its blend of precision and versatility. Drawing from years of experience on professional project teams, I’ve seen specialized intermediates fuel innovation in everything from pharmaceuticals to advanced polymers. Synthetic chemists often face a need for smart building blocks that keep complexity low while opening new doors for structural modification. This particular compound comes up more often than one might expect, mostly when researchers chase novel molecules with tight control over both reactivity and selectivity.
On paper, this molecule looks simple—a pyridine ring with a carboxylic acid group, plus bromine and fluorine atoms at key positions. In practice, the carefully chosen substitution pattern makes it a go-to reagent for meaningful transformations. The bromine offers a prime site for Suzuki or Stille cross-couplings, while the fluorine can affect both steric and electronic properties, dialing up metabolic stability or shifting the electronic push-pull balance in bioactive targets. Over the years, the addition of fluorine to aromatic compounds has proven an invaluable tactic for boosting solubility, controlling lipophilicity, or steering metabolic stability. In my own experience, biopharma clients appreciate this sort of flexibility as they move early hits toward lead candidates.
The defining feature of this molecule, besides the thoughtful placement of halogens, is its carboxylic acid group. That functional group enables simple derivatizations—think amidation, esterification, or direct coupling—giving medicinal chemists plenty to work with. Unlike plain pyridines, which often fall short on reactivity, and mono-halogenated cores, which can limit the scope of downstream modifications, the dual substitution here expands access to a wider range of functional molecules. With this one compound, it’s possible to forge new chemistries without getting locked into a single pathway.
Specification wise, 5-Bromo-3-Fluoropyridine-2-Carboxylic Acid arrives as a solid, often a fine crystalline powder. Its molecular formula—C6H3BrFNO2—suggests a tidy structure, with a molecular weight that makes purification and workup manageable. Looking at purity standards, reputable suppliers generally aim for 97% or higher, minimizing headaches for end users hunting for clean reaction profiles. Across multiple labs I’ve worked with, reliable purity and consistent physical form translate to predictable performance in reactions. Analytical chemists tend to lay eyes on sharp melting points, with solid-state NMR and HPLC readings helping confirm identity and integrity. All in all, the ease of characterization makes this compound a favorite for those who don’t want surprise variables lurking in their synthetic work.
Usage spans more than just pharmaceuticals, although that’s the most prominent field. As a key starting material in complex molecule synthesis, the compound finds a place in agrochemical development, dyes, and even specialty material research. Chemical companies and academic teams alike value its ability to streamline routes toward fluorinated or brominated heterocycles. Compared to more basic pyridine derivatives, the added functional handles offer a shortcut to diversity-oriented synthesis. Rather than building up complexity step by step, researchers can plug in this carboxylic acid and move straight to interesting scaffolds, often skipping over less efficient pathways involving metalation or multistep halogenation.
Medicinal chemistry often comes down to the art of small changes with big impact. Adding a fluorine atom at the right spot, or swapping hydrogen for bromine, can nudge biological activity in helpful ways. 5-Bromo-3-Fluoropyridine-2-Carboxylic Acid’s unique arrangement helps chemists approach these optimizations without needing to start from scratch. During hit-to-lead campaigns, teams often want to introduce a metabolically stable group, fine-tune the polarity, or add a moiety that helps molecules fit tougher biological targets. This molecule steps up to these demands. It also helps reduce time spent on protecting-group strategies, since the carboxylic acid lends itself to direct transformation into amide or ester analogues. Over several drug discovery collaborations, the ability to quickly generate analogues in parallel has saved both time and budget, which matters more than ever in today’s high-stakes research environments.
There’s also the question of selectivity. Pyridine cores show up in many enzyme inhibitors, allosteric modulators, and ion channel ligands. The specific placement of the halogens in this compound means researchers can use it as a core for SAR expansion, tweaking electronic features or hydrogen-bonding patterns as new biological data rolls in. Compared to default pyridylcarboxylic acids, the enhancements here help teams chase more potent, selective leads with real-world promise.
Every working chemist knows the landscape for pyridine derivatives is crowded. Mono-halogenated analogs see frequent use for basic coupling strategies, but their limits crop up sooner rather than later. Two halogen atoms, postioned thoughtfully around the ring, offer the kind of orthogonal reactivity that’s hard to get from simpler cousins. The presence of both bromine and fluorine, rather than two identical groups, gives users a way to tailor synthetic sequences. You can tap into coupling at one site, nucleophilic aromatic substitution at another, or use the acid for direct functionalization. Cost and supply chain factors often matter in research—this compound, synthesized from widely available starting materials, doesn’t run into the shortages and supply volatility that hit more exotic derivatives.
Some may ask whether it’s easier to make a similar compound from scratch. In reality, starting from precursor compounds like 3-fluoropyridine or other halogenated pyridines often involves tedious functional group juggling. Commercially available 5-Bromo-3-Fluoropyridine-2-Carboxylic Acid saves several synthetic steps, trims down side reactions, and helps researchers avoid costly purification headaches. In past projects, delays due to stubborn intermediates often set back entire timelines. Having a robust, shelf-stable intermediate like this one allows projects to keep momentum as new targets and ideas emerge.
In the pharmaceutical sector, every new candidate rises or falls on scale-up reliability, purity, and regulatory acceptance. This compound features properties that fit those needs—stability under common storage conditions, low risk for hazardous by-products, straightforward quality control, and compliance-readiness for early-stage toxicology. The carboxylic acid group, being one of the most “handleable” functionalities in med-chem, means teams can run parallel synthesis, fragment coupling, or late-stage modifications without worrying too much about protecting groups or capricious reactivity. Over the years, I’ve watched teams struggle with more volatile or reactive analogues that can derail SAR projects just when promising data starts to emerge.
Beyond pharma, research groups in materials science and crop protection have also taken a liking to this molecule. New herbicide classes, for example, often rely on aryl-pyridine scaffolds for selective activity. The quest to add stability, or to fine-tune aromaticity and hydrophobicity, benefits greatly from the strategic use of halogenated carboxylic acids. Early-stage researchers, especially those without big budgets, appreciate the compound’s reproducibility and relatively straightforward handling. Its crystalline form ships well and doesn’t demand specialty refrigeration, unlike some sensitive organics.
In lab settings, this molecule behaves predictably. As an organic chemist, I remember spending long hours purifying multi-halogenated pyridines with unpredictable by-products, only to find their utility limited in later steps. By contrast, the dual activation present with bromine and fluorine unlocks more productive avenues—whether in transition metal-catalyzed couplings or in sequences involving nucleophilic displacement. The acid functionality offers a clear anchor for linker attachment or fragment elaboration, simplifying life for those working at the interface of chemistry and biology.
Quality sourcing matters. Not all chemical suppliers hit the same marks for purity, batch consistency, or safety documentation. 5-Bromo-3-Fluoropyridine-2-Carboxylic Acid is no exception. Trusted vendors invest in validated synthetic routes and analytical QA processes—this means fewer impurities, greater confidence in batch-to-batch reproducibility, and fewer supply disruptions. Researchers know the pain of having a mid-project order delayed or replaced with an off-spec shipment. Keeping purchasing cycles tight and expectations clear with reliable partners reduces such headaches.
Sustainability comes up more often in discussions about specialty chemicals. While halogenated organics can present environmental handling concerns, well-run manufacturing setups capture and neutralize waste streams efficiently. Over the last decade, responsible producers have introduced greener synthetic routes, solvent recovery programs, and lifecycle tracking, minimizing downstream hazards. In my experience, buyers increasingly favor those who publish clear sustainability metrics and incident response plans.
On the safety front, this compound doesn’t pose the same risks as highly reactive nitroaromatics or volatile halogen derivatives, but it still calls for standard chemical hygiene. Proper gloves, ventilation, and disposal protocols matter, especially in academic environments where less experienced operators may work. A solid understanding of material safety data, and open lines of communication with suppliers, helps keep unexpected incidents at bay.
No molecule is perfect. In certain coupling reactions, the presence of both a carboxylic acid and two halogens may increase the need for careful optimization—especially under high-temperature or strongly basic conditions. Some users report modest solubility in polar solvents, which can complicate larger-scale preparations. During my own bench work, I found that pre-dissolving the acid in a small portion of DMF or DMSO can ease transfers and dosing. For those scaling up, incremental dilution or the use of phase-transfer conditions can help.
Intellectual property is also a concern for companies commercializing new products incorporating this scaffold. While the basic structure is well-known in the literature, many functionalized derivatives fall into tighter patent space. Keeping an eye on the latest patent filings, and consulting with IP professionals, can prevent costly legal tangles. Teams working in collaboration with academic groups or international partners should keep clear logs and publication timelines, a lesson I’ve learned the hard way when publication scooped a potential patent.
Another common challenge relates to analytical confirmation. With isomeric or closely related pyridine compounds, spectral overlap can cause confusion. Investing in high-quality reference spectra, and running both proton and carbon NMR alongside mass spec data, helps avoid misassignment at critical project stages. Several teams I’ve collaborated with have avoided major setbacks by flagging ambiguous spectra early and seeking third-party confirmation. This is especially important when funding decisions depend on early data, or when scaling up promising material for animal studies.
For pharma teams designing a focused library, this compound often serves as a smart starting point. Strategic modifications—such as amidation, Suzuki coupling, or late-stage ester synthesis—flow smoothly with this scaffold. My advice is to lock down reliable conditions on milligram scale before committing to more material, since the interplay of halogens sometimes surprises with new by-products or sluggish conversions under unfamiliar conditions.
Cross-functional teams—those working at the interface of chemistry and biology—benefit from discussing sample handling and storage in advance. The solid form stores well in a dry, cool space, and aliquots can be prepared for screening projects without much effort. Having a sample management system, even for relatively simple intermediates, pays dividends by reducing cross-contamination and mix-ups. In my own work, projects with a tracking log ran smoother and saw dividends at IP and regulatory stages.
Lab safety has come a long way, but periodic refresher sessions on halogenated aromatic compounds remain worthwhile. Even reasonably non-volatile acids like this one sometimes present unknowns when mixed with oxidizers or strong bases. Teams should dedicate a few protocol review sessions each year to make sure procedures remain current. My own teams avoided at least one near-miss by holding open conversations about the quirks of similar compounds just before project launches.
Chemical innovation rarely stands still. With greater interest in hybrid small molecule-biologic drugs, the demand for functional and modifiable scaffolds like this one looks set to grow. Advances in coupling chemistry, machine learning-driven synthetic planning, and high-throughput screening keep highlighting the need for robust, flexible starting points that help researchers try new ideas without re-inventing the wheel. My own forecasts, based on industry discussions and hands-on project planning, suggest this compound will remain relevant as long as drug discovery and material development keep pushing for faster, more modular frameworks.
As new analytical technologies and purification methods spread, the ease of working with this molecule should only increase. Analytical service providers now offer more advanced NMR and mass spectrometry, letting teams confirm product identity and track synthetic intermediates far faster than before. This should give younger researchers, or those in less well-funded environments, the ability to take full advantage of versatile intermediates without stumbling over technical hurdles.
Across research communities striving for breakthroughs in life sciences, materials, and agrochemicals, 5-Bromo-3-Fluoropyridine-2-Carboxylic Acid holds a valuable place. For those building the next generation of functional molecules, it offers a practical blend of reactivity, reliability, and modifiability. Experience tells me that even as project goals shift and technologies evolve, the virtues of a well-designed building block remain constant. Reliable intermediates clear away synthetic barriers, open new fields of study, and let both aspiring and veteran chemists do more with each experiment.